Drug Discovery Opinion

New research has shown that compounds that affect cellular energy status could also be used to treat hepatitis C virus (HCV) infections. Metformin, which is used to treat type II diabetes, and 5-amino-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide (AICAR), which has been shown to mimic the beneficial effects of exercise in mice, stimulate AMP-activated protein kinase (AMPK). AMPK is a key sensor of cellular energy status and regulates both lipid and glucose metabolism to maintain cellular energy balance and protect against metabolic stress. An increase in the AMP/ATP ratio initiates an AMPK-mediated switch from activities that consume ATP, such as lipid production, to activities that produce ATP, such as lipid and glucose oxidation.

Infection with viruses might be expected to activate AMPK because of the energy demands put on the cell by viral replication, but research led by scientists at the University of Leeds has shown instead that HCV switches off AMPK so that the cell continues to produce the lipids needed to provide new viral particles with a protective outer coat. When the team treated HCV-infected cells with metformin or AICAR, AMPK activity was restored and viral replication was inhibited.

The team plan to carry out a small scale clinical trial to investigate the effects of AMPK activators in HCV infection and hope that such drugs may provide much-needed new treatments for HCV.

The study is published in the Proceedings of the National Academy of Science.

Related posts:

1. Blocking Lipid Droplet Hydrolysis May Be Beneficial Fatty acids can be stored as triacylglycerol in lipid droplets, typically within adipose tissue, and then later released by the...
2. New Role for Multi-Tasking Lipid Since the mid-1990s, sphingosine-1-phosphate (S1P) has become one of the most widely studied lipid mediators. Many of the biological effects...
3. Host Kinases Linked to HCV Infection Globally, around 200 million people are infected with Hepatitis C virus (HCV). Infection generally leads to chronic liver disease, albeit...
4. Targeting Influenza A Nucleoprotein Although the recent sporadic outbreaks of influenza A virus H5N1 and of a new variant of H1N1 in 2009 were...
5. Study Identifies Receptor for Potentially Fatal Infection Mucormycosis is a potentially fatal infection of the sinuses, brain, or lungs, which is most commonly caused by the fungus...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Friday, June 11th, 2010 at 8:54 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.